{"DataElement":{"publicId":"2181363","version":"2","preferredName":"Myeloma Diagnosis Stage","preferredDefinition":"information related to the stage of myeloma at diagnosis.","longName":"MYE_DX_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2181360","version":"1","preferredName":"Myeloma Diagnosis","preferredDefinition":"information related to diagnosis of myeloma.","longName":"MYE_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177047","version":"1","preferredName":"Myeloma","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001) -- 2003","longName":"Myeloma","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AA0-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177541","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"Diagnosis","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C6-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D404D5D0-A251-36AA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181362","version":"2","preferredName":"Myeloma Diagnosis Stage","preferredDefinition":"information related to the stage of myeloma at diagnosis.","longName":"MYELOMA_DX_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"II - Fitting neither Stage I or Stage III","valueDescription":"II - fitting neither Stage I or Stage III","ValueMeaning":{"publicId":"2568456","version":"1","preferredName":"II - fitting neither Stage I or Stage III","longName":"2568456","preferredDefinition":"II - fitting neither Stage I or Stage III","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D875-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B21E2AC5-E418-5BEE-E053-4EBD850A6617","beginDate":"2004-03-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-20","modifiedBy":"ONEDATA","dateModified":"2020-10-20","deletedIndicator":"No"},{"value":"I - ALL of the following must be present","valueDescription":"I - ALL of the following must be present (hemoglobin >10 g/dL; serum calcium <10.5 mg/dL; urine light chains <4 g/24 hrs; normal bones on radiograph or solitary plasmacytoma; IgG <5 g/dL; IgA <3 g/dL)","ValueMeaning":{"publicId":"7473977","version":"1","preferredName":"I - ALL of the following must be present (hemoglobin >10 g/dL; serum calcium <10.5 mg/dL; urine light chains <4 g/24 hrs; normal bones on radiograph or solitary plasmacytoma; IgG <5 g/dL; IgA <3 g/dL)","longName":"7473977","preferredDefinition":"I - ALL of the following must be present (hemoglobin >10 g/dL; serum calcium <10.5 mg/dL; urine light chains <4 g/24 hrs; normal bones on radiograph or solitary plasmacytoma; IgG <5 g/dL; IgA <3 g/dL)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B21E2AC5-E47F-5BEE-E053-4EBD850A6617","latestVersionIndicator":"Yes","beginDate":"2020-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-20","modifiedBy":"ONEDATA","dateModified":"2020-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B21E2AC5-E498-5BEE-E053-4EBD850A6617","beginDate":"2020-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-20","modifiedBy":"ONEDATA","dateModified":"2020-10-20","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B21E2AC5-E436-5BEE-E053-4EBD850A6617","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-20","modifiedBy":"ONEDATA","dateModified":"2020-10-20","deletedIndicator":"No"},{"value":"III - one of the following must be present","valueDescription":"III - one of the following must be present (hemoglobin <8.5 g/dL; serum calcium >12 mg/dL; urine light chains >12 g/24 hrs; advanced lytic bone lesions (scale 3 = extensive skeletal destruction & major fractures); IgG >7 g/dL; IgA >5 g/dL)","ValueMeaning":{"publicId":"7473976","version":"1","preferredName":"III - one of the following must be present (hemoglobin <8.5 g/dL; serum calcium >12 mg/dL; urine light chains >12 g/24 hrs; advanced lytic bone lesions (scale 3 = extensive skeletal destruction & major fractures); IgG >7 g/dL; IgA >5 g/dL)","longName":"7473976","preferredDefinition":"III - one of the following must be present (hemoglobin <8.5 g/dL; serum calcium >12 mg/dL; urine light chains >12 g/24 hrs; advanced lytic bone lesions (scale 3 = extensive skeletal destruction & major fractures); IgG >7 g/dL; IgA >5 g/dL)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B21E2AC5-E45C-5BEE-E053-4EBD850A6617","latestVersionIndicator":"Yes","beginDate":"2020-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-20","modifiedBy":"ONEDATA","dateModified":"2020-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B21E2AC5-E475-5BEE-E053-4EBD850A6617","beginDate":"2020-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-20","modifiedBy":"ONEDATA","dateModified":"2020-10-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B21E2AC5-E402-5BEE-E053-4EBD850A6617","latestVersionIndicator":"Yes","beginDate":"2020-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-20","modifiedBy":"CAMPBELB","dateModified":"2020-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3461037","version":"1","longName":"Myeloma","context":"NCIP"}]},{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964888","version":"1","longName":"2016r1: Myeloma Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461152","version":"1","longName":"Hematologic Staging","context":"NCIP"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PCDpre_lab_diag_durie_salmon_stage","type":"OID, ACRIN","context":"NHLBI"},{"name":"PerformedClinicalInterpretation:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"pre_ted_mm_stg_diag_1_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_durie_salmon_stage","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_PCD_durie_salmon_stage","type":"NMDP_FN","context":"NHLBI"},{"name":"PCDpre_lab_diag_durie_salmon_stage","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"-COMMENT","type":"COMMENT","description":"Add instruction on template form: at Initial Diagnosis","url":null,"context":"CTEP"},{"name":"Durie-Salmon Stage","type":"Preferred Question Text","description":"Durie-Salmon Stage","url":null,"context":"CTEP"},{"name":"Stage at Diagnosis Salmon & Durie:","type":"Alternate Question Text","description":"Stage at Diagnosis Salmon & Durie:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2181363","type":"BRIDG Mapping Path","description":"PerformedDiagnosis > AssessedResultRelationship > PerformedObservation > PerformedClinicalInterpretation.value WHERE PerformedObservation.methodCode = \"Durie-Salmon\" AND PerformedDiagnosis.bodySystemCode = \"Renal\" AND PerformedDiagnosis.value = \"Myeloma\" AND AssessedResultRelationship.typeCode = \"staging\"","url":null,"context":"NHLBI"},{"name":"What was the Durie-Salmon staging?","type":"Application Standard Question Text","description":"What was the Durie-Salmon staging?","url":null,"context":"NHLBI"},{"name":"What was the Durie-Salmon staging?","type":"Alternate Question Text","description":"What was the Durie-Salmon staging?","url":null,"context":"NHLBI"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B21E77C9-37C8-5BF8-E053-4EBD850AAAD9","latestVersionIndicator":"Yes","beginDate":"2020-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-20","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Add new VD with updated PVs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}